How Much Did Adherium Raise?
Funding & Key Investors

Adherium, an international Respiratory eHealth company, has secured significant capital, with its total funding reaching $44.9M and its most recent financing round amounting to $900K. This enterprise-level investment underscores the company's strategic importance in the digital health sector, particularly in enhancing patient adherence and remote monitoring for respiratory conditions like severe asthma and COPD.

What is Adherium?

Adherium
SoftwareHealthcare SoftwareHealthcare Services

Adherium Limited specializes in patient adherence, remote monitoring, and data management solutions within the respiratory eHealth space. Their core offering includes the Hailie Smartinhaler technology and a cloud-based platform designed to optimize medication adherence for individuals managing severe asthma and COPD. By integrating telehealth and remote monitoring advancements, Adherium aims to mitigate healthcare costs associated with medication non-adherence, serving patients, physicians, payers, and healthcare providers.

How much funding has Adherium raised?

Adherium has raised a total of $44.9M across 8 funding rounds:

2015

Stock Offering

$25.6M

Corporate Investment

$3M

2016

Share Placement

$5.9M

2019

Debt

$1.8M

Debt

$1.2M

2020

Private Equity

$3.5M

Debt

$3M

2025

Other Financing Round

$900K

Stock Issuance/Offering (2015): $25.6M with participation from Undisclosed

Corporate Investment (2015): $3M led by AstraZeneca

Share Placement (2016): $5.9M supported by Fidelity Investments

Debt (2019): $1.8M featuring Summatix Pty Limited and One Funds Management Limited

Debt (2019): $1.2M backed by Trudell Medical Limited

Private Equity (2020): $3.5M with participation from Undisclosed

Debt (2020): $3M led by Viburnum

Other Financing Round (2025): $900K supported by Trudell Medical and Phillips Asset Management

Key Investors in Adherium

Trudell Medical

Trudell Medical Ltd focus is on respiratory care, select areas of the hospital operating room and providing pathways for virtual care. The company's vision is to provide patients throughout the world with medical devices and services that make their lives better. The company manufactures and globally market some of the leading brands in respiratory care including the AeroChamber® brand of spacers, the Aerobika® OPEP devices, and the Aeroeclipse® brand of nebulizers.

Phillips Asset Management

Phillips Management is a full-service property management company founded in 1989, focused on alleviating the burdens of property management for owners of office buildings, medical offices, retail spaces, and industrial properties. With over 70 years of expertise, they offer a comprehensive approach that encompasses maintenance, tenant relations, and property optimization. The company tailors its services to meet the unique challenges and opportunities presented by various property types, ensuring efficient management and growth in value. Based in New Jersey, Phillips Management is dedicated to delivering exceptional results and peace of mind to its clients.

AstraZeneca

AstraZeneca focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca is based in the United Kingdom.

What's next for Adherium?

The recent major strategic investment in Adherium signals a pivotal growth phase, likely enabling the company to further scale its operations, enhance its technological platform, and expand its market reach. This capital infusion is expected to bolster its position in the competitive digital health landscape, potentially leading to new product developments or strategic partnerships aimed at improving respiratory care outcomes and reducing the economic burden of chronic respiratory diseases.

See full Adherium company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Financial SoftwareSoftwareCredit Card ProcessingFinance
Business Intelligence (BI) SoftwareSoftwareBusiness ServicesSoftware Testing
Customer Engagement PlatformsSoftwareAdvertising NetworksBusiness Services
Security SoftwareSoftware

Frequently Asked Questions Regarding Adherium Financial Insights

What are the most recent funding rounds that Adherium has completed, and what were the funding rounds?
Adherium has recently completed 3 funding rounds: Other Financing Round on May 19, 2025, Debt on Oct 27, 2020, Private Equity on Mar 3, 2020.
What is the total amount of funding Adherium has raised to date?
Adherium has raised a total of $44.9M in funding to date.
How many funding rounds has Adherium completed?
Adherium has completed 3 funding rounds.
How much funding did Adherium raise in its most recent funding round?
Adherium raised $900K in its most recent funding round.
Who are the lead investors in Adherium's latest funding round?
The lead investor in Adherium's latest funding round was Trudell Medical. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Adherium's history?
The largest funding round in Adherium's history was $25.6M.
See more information about Adherium